Shell Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-46,970	Closed	-$160K	–	1257
2023 Q3	$160K	Buy	46,970 +41,493	+758%	+$230K	0.01%	971
2023 Q2	$40K	Sell	5,477 -2,737	-33%	-$25.4K	﹤0.01%	1232
2023 Q1	$85K	Sell	8,214 -29	-0.4%	-$351	﹤0.01%	1140
2022 Q4	$97K	Sell	8,243 -1,673	-17%	-$25.9K	﹤0.01%	1159
2022 Q3	$208K	Sell	9,916 -2,600	-21%	-$72.4K	0.01%	996
2022 Q2	$388K	Buy	12,516 +21	+0.2%	+$717	0.01%	848
2022 Q1	$513K	Sell	12,495 -1,848	-13%	-$81.5K	0.01%	801
2021 Q4	$623K	Buy	14,343 +67	+0.5%	+$3.03K	0.01%	795
2021 Q3	$715K	Sell	14,276 -610	-4%	-$36.9K	0.02%	677
2021 Q2	$938K	Buy	14,886 +3,201	+27%	+$206K	0.02%	607
2021 Q1	$1.09M	Sell	11,685 -70	-0.6%	-$7.17K	0.02%	507
2020 Q4	$1.05M	Hold	11,755	–	–	0.02%	495
2020 Q3	$1.22M	Hold	11,755	–	–	0.03%	418
2020 Q2	$930K	Sell	11,755 -151	-1%	-$11.3K	0.02%	455
2020 Q1	$689K	Sell	11,906 -181	-1%	-$10.4K	0.02%	539
2019 Q4	$652K	Sell	12,087 -285	-2%	-$15.5K	0.01%	750
2019 Q3	$647K	Sell	12,372 -107	-0.9%	-$4.99K	0.01%	763
2019 Q2	$603K	Sell	12,479 -286	-2%	-$13.7K	0.01%	831
2019 Q1	$645K	Hold	12,765	–	–	0.01%	787
2018 Q4	$757K	Sell	12,765 -1,100	-8%	-$70.9K	0.02%	641
2018 Q3	$913K	Hold	13,865	–	–	0.02%	712
2018 Q2	$700K	Sell	13,865 -743	-5%	-$38.7K	0.01%	831
2018 Q1	$769K	Hold	14,608	–	–	0.02%	775
2017 Q4	$679K	Sell	14,608 -3,639	-20%	-$153K	0.01%	804
2017 Q3	$738K	Sell	18,247 -500	-3%	-$18.1K	0.02%	722
2017 Q2	$636K	Hold	18,747	–	–	0.01%	821
2017 Q1	$544K	Sell	18,747 -1,311	-7%	-$39.9K	0.01%	872
2016 Q4	$659K	Sell	20,058 -175	-0.9%	-$5.25K	0.02%	798
2016 Q3	$638K	Buy	+20,233	New	+$588K	0.01%	780